Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma

scientific article published on 01 September 2006

Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JAAD.2006.04.025
P698PubMed publication ID16908377

P2093author name stringMarie-France Demierre
Josephine Taverna
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)543-544
P577publication date2006-09-01
P1433published inJournal of the American Academy of DermatologyQ15757046
P1476titleMirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma
P478volume55

Reverse relations

cites work (P2860)
Q38360710Chronic pruritus in the elderly: pathophysiology, diagnosis and management
Q35148381Chronic pruritus: a paraneoplastic sign
Q38594826Malignancy-associated pruritus
Q64069308Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel
Q38452688Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
Q24615751New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma
Q28075343Pruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative Review
Q37979593Pruritus in cutaneous T-cell lymphoma: a review
Q37902325Pruritus: management algorithms and experimental therapies.
Q37827172Targeted treatment of pruritus: a look into the future
Q49644954The vicious cycle of itch and anxiety
Q37738911Therapy of pruritus
Q88026912[Management of cutaneous lymphomas]

Search more.